» Articles » PMID: 22469986

Rage Signalling Promotes Intestinal Tumourigenesis

Overview
Journal Oncogene
Date 2012 Apr 4
PMID 22469986
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Development of colon cancer is a multistep process that is regulated by intrinsic and extrinsic cellular signals. Extrinsic factors include molecular patterns that are derived from either pathogens (PAMPs) or cellular damage (DAMPs). These molecules can promote tumourigenesis by activation of the innate immune system, but the individual contribution of ligands and their receptors remains elusive. The receptor for advanced glycation end products (Rage) is a pattern recognition receptor that binds multiple ligands derived from a damaged cell environment such as Hmgb1 and S100 protein. Here we show that Rage signalling has a critical role in sporadic development of intestinal adenomas, as Apc(Min/+) Rage(-/-) mice are protected against tumourigenesis.

Citing Articles

Uncovering novel mechanisms of chitinase-3-like protein 1 in driving inflammation-associated cancers.

Fan Y, Meng Y, Hu X, Liu J, Qin X Cancer Cell Int. 2024; 24(1):268.

PMID: 39068486 PMC: 11282867. DOI: 10.1186/s12935-024-03425-y.


Contributions of the receptor for advanced glycation end products axis activation in gastric cancer.

Rojas A, Lindner C, Schneider I, Gonzalez I, Morales M World J Gastroenterol. 2023; 29(6):997-1010.

PMID: 36844144 PMC: 9950863. DOI: 10.3748/wjg.v29.i6.997.


Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications.

Yu G, Li S, Wei R, Jiang Z J Diabetes Res. 2022; 2022:1747326.

PMID: 35296101 PMC: 8920658. DOI: 10.1155/2022/1747326.


Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.

Azizian-Farsani F, Abedpoor N, Sheikhha M, Gure A, Nasr-Esfahani M, Ghaedi K Front Oncol. 2020; 10:552283.

PMID: 33117687 PMC: 7551201. DOI: 10.3389/fonc.2020.552283.


SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE).

Wu C, Du X, Tang L, Wu J, Zhao W, Guo X Front Immunol. 2020; 11:1767.

PMID: 32973746 PMC: 7472961. DOI: 10.3389/fimmu.2020.01767.